Magnesium sulfate therapy in preeclampsia and eclampsia

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Pharmacology

Background:

• Preeclampsia and eclampsia are serious hypertensive disorders of pregnancy.
• Seizure prophylaxis is crucial for managing these conditions.
• Magnesium sulfate is a commonly used agent for seizure prevention.

Purpose of the Study:

• To review evidence on the efficacy, benefits, and risks of magnesium sulfate for seizure prophylaxis in preeclampsia and eclampsia.
• To assess the current literature on magnesium sulfate's role in managing hypertensive disorders of pregnancy.

Main Methods:

• Systematic review of English-language literature (MEDLINE, 1966-1998).
• Inclusion of randomized controlled trials, retrospective reviews, and observational studies.
• Keywords: magnesium sulfate, seizure, preeclampsia, eclampsia, hypertension in pregnancy.

Main Results:

• Magnesium sulfate significantly reduced recurrent seizures in eclampsia compared to phenytoin or diazepam.
• In severe preeclampsia, magnesium sulfate dramatically lowered seizure incidence versus antihypertensive agents.
• Potential risks include increased labor duration, cesarean rates, postpartum bleeding, respiratory depression, and maternal death from overdose.

Conclusions:

• Magnesium sulfate is effective for seizure prophylaxis in eclampsia and severe preeclampsia.
• Evidence supports its use in these conditions.
• Further randomized controlled trials are needed for mild preeclampsia and gestational hypertension.